Dr. Andrea Galbiati is giving a presentation about Philochem’s FAP ligand platform on June 9th, entitled “Development of Multivalent OncoFAP Derivatives for the Tumor-Targeted Delivery of Theranostic Radionuclides”.

Dr. Samuele Cazzamalli is presenting a poster about Philochem’s new radioligand on June 8th, entitled “First-in-class ACP3 high-affinity ligands isolated from DNA-Encoded Chemical Libraries for the delivery of radionuclides against prostate cancer”

Follow the link for more details.